ALT-803 - Altor BioScience
June 2016 Potency against Solid and Hematological Tumors in Preclinical Studies: In various solid and hematological tumor models, ALT-803 exhibits impressive, durable anti-tumor activity as a …
Download ALT-803 - Altor BioScience
Information
Domain:
Source:
Link to this page:
Related documents
ERYTECH to Present Two Posters at AACR
erytech.com1 ERYTECH to Present Two Posters at AACR PRESS RELEASE Lyon (France), March 17, 2016 – ERYTECH (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company developing innovative ‘tumor starvation’ treatments for acute leukemia and
Chemotherapy Sequencing Guide – For therapies given on …
sites.mckesson.comBevacizumab Bleomycin Carboplatin Cisplatin Cyclophosphamide Cytarabine Dacarbazine Docetaxel Doxorubicin Epirubicin Etoposide Fludarabine Fluorouracil Gemcitabine ...
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET 1. PRODUCT NAME SUTENT (sunitinib 12.5mg capsules) SUTENT (sunitinib 25 mg capsules) SUTENT (sunitinib 37.5 mg capsules)
Merck Pipeline - Merck.com | Homepage
www.merck.comPhase 2 Phase 2 Phase 3 Phase 3 Phase 3 Cancer Advanced solid tumors Cutaneous Squamous Cell Carcinoma Diabetes mellitus Ovarian MK Prostate
MEDICARE HOSPICE CRITERIA
www.nhhpco.orgRev.10/11 MEDICARE HOSPICE CRITERIA (condensed for quick reference; final decisions require physician judgment and full LCDs) Need Part I OR (Part II + Part III)
Pfizer Pipeline
www.pfizer.comPfizer Pipeline Snapshot 4 Pipeline represents progress of R&D programs as of October 27, 2015 Included are 56 NMEs, 20 additional indications, plus 8 biosimilars
Evaluation of Cutaneous Skin Rash in Subjects Treated with ...
www.mpmmedicalinc.comEvaluation of Cutaneous Skin Rash in Subjects Treated with Regenecare™ Topical Gel (Collagen, Aloe vera, & 2% Lidocaine) During Erbitux® and Combination Therapies for Cancer